Stephen S. Yoder
2022
In 2022, Stephen S. Yoder earned a total compensation of $2.1M as Chief Executive Officer at Pieris Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $197,689 |
|---|---|
| Option Awards | $1,288,128 |
| Salary | $564,826 |
| Other | $12,200 |
| Total | $2,062,843 |
Yoder received $1.3M in option awards, accounting for 62% of the total pay in 2022.
Yoder also received $197.7K in non-equity incentive plan, $564.8K in salary and $12.2K in other compensation.
Rankings
In 2022, Stephen S. Yoder's compensation ranked 1,709th out of 5,739 executives tracked by ExecPay. In other words, Yoder earned more than 70.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,709 out of 5,739 | 70th |
Division Manufacturing | 895 out of 3,128 | 71st |
Major group Chemicals And Allied Products | 361 out of 1,416 | 75th |
Industry group Drugs | 330 out of 1,317 | 75th |
Industry Pharmaceutical Preparations | 236 out of 963 | 76th |
Source: SEC filing on November 6, 2024.
Yoder's colleagues
We found one more compensation record of an executive who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2022.
2022
Thomas Bures
Pieris Pharmaceuticals